|Year : 2018 | Volume
| Issue : 4 | Page : 349-356
Human carbonic anhydrase: Purification and characterization study in thalassemia major patients compared to healthy subjects
Salwa Saleh Hussein, Israa Ghassan Zainal
Department of Chemistry, College of Science, Kirkuk University, Kirkuk, Iraq
|Date of Web Publication||20-Dec-2018|
Israa Ghassan Zainal
Department of Chemistry, College of Science, Kirkuk University, Kirkuk
Source of Support: None, Conflict of Interest: None
Background: Carbonic anhydrase (CA) catalyzes the reversible reaction of converting carbon dioxide to bicarbonate. Objective: This study was aimed to isolate and purify human erythrocytes CA and study its physicochemical properties of the enzyme reaction for ß-thalassemia major patients. Materials and Methods: The blood samples included 61 samples of blood (31 males and 30 females) from ß-thalassemia patients visited Azadi Hospital/Kirkuk city. Healthy individuals as control group included 40 participants. The separated fractions were obtained using four steps: extraction by ethanol and chloroform, ammonium sulfate precipitation, dialysis, and gel filtration chromatography; finally, the CA was analyzed by polyacrylamide gel electrophoresis. Results: The CA activity showed significant (P ≤ 0.05) decrease, total protein showed nonsignificant (P ≥ 0.05) increase, and specific activity significantly (P ≤ 0.05) increased in patients group compared to healthy individuals. CA was partially purified with a factor of 22.5 and 18 by extraction with ethanol and chloroform and 1.5,1.4 for Fraction I and 1,2 for Fraction II using gel filtration chromatography. The optimum conditions for the CA reaction in patients group were enzyme concentration (6 μl), substrate concentration (6 Mm), pH = 7.4, and temperature 37°C. The electrophoresis study indicated that the bands of CA in patients group showed bands with less intensity than the bands in healthy individuals. Conclusion: The best method to purify CA from human erythrocytes with high recovery and fold of purification was ethanol–chloroform extraction.
Keywords: Carbonic anhydrase, electrophoresis, gel filtration, purification, ß-thalassemia
|How to cite this article:|
Hussein SS, Zainal IG. Human carbonic anhydrase: Purification and characterization study in thalassemia major patients compared to healthy subjects. Med J Babylon 2018;15:349-56
|How to cite this URL:|
Hussein SS, Zainal IG. Human carbonic anhydrase: Purification and characterization study in thalassemia major patients compared to healthy subjects. Med J Babylon [serial online] 2018 [cited 2020 Oct 22];15:349-56. Available from: https://www.medjbabylon.org/text.asp?2018/15/4/349/248049
| Introduction|| |
Carbonic anhydrase (CA) (EC 126.96.36.199) catalyzes the reversible reaction of converting carbon dioxide (CO2) to bicarbonate (HCO3−) as in the equation below:
CO2 + H2O ↔ H+ + HCO3−
CA is a Zn-metalloenzyme present in plants, animals, and microorganisms, suggesting that the CA has many diverse metabolic roles in living organisms.,, CAs have seven evolutionarily unrelated CA-gene families including α-, β-, γ-, δ-, ζ-, η-, and θ- CAs with no structural similarity; mammals have only α-CAs with multiple isoforms of the enzyme. The family of CA is known to contain 15 human α-CA isoforms, all of which differ in their catalytic rates, inhibitor sensitivity and selectivity, cellular localization, and tissue distribution.,, CAs are involved in various physiological roles including “fluid secretion, acid/base balance thus pH regulation, gluconeogenesis, ureagenesis, gastric acid production, and transport of CO2 from the tissues to the lungs (in the form of HCO3−)” through blood.,, CO2 released as a part of respiration by the tissues is not very soluble in blood and thus, to be transported, it is converted to HCO3 − by human CA II (HCA II)., Reduction in CA activity decreases the secretion of HCO3 − and aqueous humor, thereby reducing the pressure.,,, HCA II aids in the conversion of H2O and CO2 into HCO3 − and a proton through two steps called “ping-pong mechanism” as in the equations below:
E: Zn − OH-+ CO2 ↔ E: Zn − H2O + HCO3− (reaction 1).
E: Zn − H2O + B↔ E: ZnOH− + BH+ (reaction 2).
The hydration step showed ( first step) the zinc-bound hydroxide which acts as a nucleophile, attacking the CO2, and ultimately forming HCO3−, this prompts H2O molecule bound to the Zn (reaction 1). The second step (reaction 2) recovers the Zn-bound hydroxide through a proton transfer mechanism through “His64” in HCA II to solvent B.,,,, Erythrocytes CA has been investigated to link with various pathological conditions including diabetes mellitus, hypertension, lipid disorders, anemia, sickle-cell disease, and leukemia.,,,,
Based on the above facts, the present study estimates the CA activity in the erythrocytes of patients with ß-thalassemia compared to healthy individuals to look at its use as a surrogate marker in patients with ß–thalassemia this study also including characterizing the physicochemical properties of the CA reaction after purified from the erythrocytes of patients with ß-thalassemia and healthy individuals. This CA has been purified by extraction using ethanol and chloroform and ammonium sulfate (AS) precipitation, followed by gel-filtration chromatography.
| Materials and Methods|| |
Chemicals and subjects
All the chemicals were commercial products of the purest quality. Sepharose 4B and p-nitrophenyl acetate were purchased from Solarbio Company. Sixty-one sample of blood (31 males and 30 females) from ß-thalassemia patients with age ranged 2–32 years were selected in this study. Those patients visited Azadi hospital/Kirkuk city/Iraq, during the period from April to October 2017. All patients were subjected to a personal interview using specially designed questionnaire format of full history with detailed information. Healthy individuals as control group included forty participants (13 males and 27 females) with the same age range as patients, any case may interfere with this study such as diabetes mellitus, hypertension, anemia, and liver diseases were discarded.
Using a disposable syringe, 2–3 ml of blood was collected by venipuncture in glass tubes within ethylenediaminetetraacetic acid-K3 as an anticoagulant. The tubes were centrifuged for 10 min with 704 × g. The plasma was separated from the cells and buffy coat removed. The packed red cells were washed three times with normal saline (0.9% NaCl) and were then lysis with ice cold water, then stored at −20°C until analysis.
Determination of total protein
Quantitative protein determination was achieved by absorbance measurements at 660 nm according to the Lowry method 1951, using bovine serum albumin as a standard.
Assay of carbonic anhydrase activity
CA activity was determined as mentioned by Verpoorte et al., with the modification described by Parui et al. using a spectrophotometer. The esterase activity of CA was determined from the hydrolysis rate of 3 mM p-nitrophenyl acetate to p-Ntro phenol. The assay system contained 6 μL of hemolysate placed in 1 cm spectrometric cell containing 744 μL of 0.05 M Tris-HCl, pH 7.4, and 750 μL of p-nitrophenyl acetate. The change in the absorbance at 348 nm was measured over the period of 3 min before and after adding the sample. The absorbance was measured by an ultraviolet (UV)-Vis spectrophotometer (Shimadzu UV-2600 Spectrophotometer). One unit of enzyme activity was expressed as μmol of p-nitrophenol released/min/μL from hemolysate at room temperature 25°C.,
Purification of carbonic anhydrase
All the purification steps were carried out at a temperature of 4°C:
- Extraction with chloroform and ethanol: Solvent proportion (0.6 ml of H2O, 0.4 ml of ethanol, and 0.5 ml chloroform) was added drop by drop to 1.5 ml from red blood cells hemolysate (the sample set in an ice bath with stirring continuously) for 90 min, then the sample was centrifuged at 784 × g for 30 min to remove excess of chloroform and ethanol. The precipitate was dissolved in 1 ml of 0.05M Tris-HCl buffer (pH-7.4). Finally, CA activity and protein concentration were determined for each separated fraction
- By AS precipitation: Three milliliters of the obtained sample from Step 1 above was first brought to 50% saturation with solid AS (the sample set in ice bath with stirring slowly and continuously). After resting for 14 h at 4°C, the sample centrifuged at 948.64 × g and 4°C for 30 min, then redissolved in 1 ml of 0.05M Tris-HCl buffer (pH-7.4). Both enzyme activity and protein concentration were determined for each separated fraction
- Dialysis against buffer: The obtained AS precipitate (enzyme solution) was dialyzed in the presence of 0.05M Tris-HCl buffer at pH 7.4, overnight at 4°C with changing the buffer solution each 6 h. Fractions were checked in terms of both protein concentration and CA activity
- Gel-filtration chromatography: The sample from the Step 3 above was further purified by gel-filtration chromatography on Sepharose 4B resin. Sepharose 4B resin was applied to an empty column (38 × 0.7) cm and equilibrated with 0.05M Tris-HCl buffer, pH 7.4. The sample containing about 1–5 mg/ml of total protein (TP) was loaded on the Sepharose 4B column equilibrated as aforementioned. Fractions of 1 ml/5 min were collected, and the absorbance of protein was read at 280 nm. Enzyme activity and protein concentration of the partially purified samples were checked at 348 and 660 nm, respectively; tubes with CA activity were collected for physicochemical properties of the enzyme reaction studies.
Discontinuous polyacrylamide gel electrophoresis (Laemmli method)
Polyacrylamide gel electrophoresis (PAGE) was carried out according to the Laemmli method for the crude and partially purified samples to locate the position of CA bands. Gel was stained with Coomassie Brillant Blue G-250.
Statistical analysis was performed with GraphPad Prism 6.0 (GraphPad Software, Inc., San Diego, CA), values were expressed as mean ± standard deviation [SD]) and P ≤ 0.05 was considered as statistically significant. The comparison of mean ± SD was performed using the Student's t-test. Statistical significance was defined as P ≤ 0.05.
| Results|| |
The native CA was isolated and purified to homogeneity at 4°C from the erythrocytes of ß-thalassemia patients and healthy individuals, then CA activity, specific activity, and TP were determined and the results were mentioned as mean ± SD as present in [Table 1].
|Table 1: Carbonic anhydrase activity, specific activity, and total protein in the sera of ß-thalassemia patients|
Click here to view
The results indicated that there was nonsignificant increase (P ≥ 0.05) in the TP concentration, significant (P ≤ 0.05) decrease and increase in the activity and specific activity of CA, respectively, in the patients group compared to healthy individuals. The results of CA activity disagreed with Midiwo et al., they studied the activity of CA in children with sickle-cell anemia and found that there was significant elevation in the activity of CA. Osterman et al. found an increase in serum CA activity in all patients with muscular dystrophy, chronic polymyositis, and amyotrophic lateral sclerosis and in many with myasthenia gravis. To the best of our knowledge, there is no study to evaluate the activity and specific activity of erythrocytes CA in the patients with ß-thalassemia. This study also examined the purification and characterization of crude and partially purified CA reaction for the ß-thalassemia patients compared to healthy individuals [Table 2] and [Table 3].
|Table 2: Purification steps for carbonic anhydrase of ß-thalassemia patients|
Click here to view
|Table 3: Purification steps for carbonic anhydrase of healthy individuals|
Click here to view
The results indicated that most of the CA activity was recovered in the soluble fraction of cell extract after using ethanol–chloroform method; the specific activity of the CA in ß-thalassemia patients sample increased from 0.762 to 16.4 U/mg and from 0.762 to 13.58 U/mg in healthy individuals after extraction with ethanol and chloroform, then decreased after using another steps of purification. The fold of purification and the yield % were also increased after extraction with chloroform and ethanol, then decreased for the two studied groups.
Contaminants of proteins were precipitated by the addition of solid AS (50% saturation). Following the AS precipitation, the CA activity was detected in the supernatant fraction, which was fractioned by gel-filtration chromatography for both healthy individuals and ß-thalassemia patients samples [Figure 1] and [Figure 2].
|Figure 1: Protein absorption at 280 nm of the elution fractions for patients and healthy individuals|
Click here to view
|Figure 2: Elution volume of the human carbonic anhydrase for patients and healthy individuals|
Click here to view
From [Figure 2], the CA appeared with two Fractions I and II. The second part of this study was aimed to evaluate the physicochemical properties (optimum conditions) of CA reaction in the crude and Fractions (I and II) of patients and healthy individuals. [Figure 3] represents the optimum CA concentration in all studied groups, and it is clear that CA activity elevated with increasing the volume of the added serum to the CA reaction; the volume of CA used was 6 μl as the optimum concentration of CA.
|Figure 3: Optimum carbonic anhydrase concentration (volume) for all the studied groups|
Click here to view
The effect of different substrate concentrations on the activity of CA in all studied groups is presented in [Figure 4].
|Figure 4: Optimum substrate concentration of the carbonic anhydrase in all the studied groups|
Click here to view
From [Figure 4], the results of the crude and partially purified CA fractions (I and II) samples appeared with hyperbolic figure, while the results appeared with S shape after partially purified, the optimum substrate concentration was 6 mM for all studied groups. The values of Km and Vmax are represented in [Table 4] (calculated from Lineweaver–Burk plot) for all studied groups.
|Table 4: Km and Vmax for all studied groups (calculated from Lineweaver-Burk plot)|
Click here to view
The results indicated that the affinity of CA to its substrate increased in the partially purified samples compared to crude samples [Table 4]. The optimum (pH and temperature) for CA reaction of the human erythrocyte in all studied groups is represented in [Figure 5] and [Figure 6], respectively, and found equal to 7.4 and 37°C for patient group.
|Figure 5: Optimum pH of (crude and partially purified) carbonic anhydrase in all the studied groups|
Click here to view
|Figure 6: Optimum temperature of (crude and partially purified) carbonic anhydrase in all the studied groups|
Click here to view
[Figure 7]a represents the PAGE (10%) for the CA of the crude sera of ß-thalassemia patients and healthy individual samples and [Figure 7]b for the crude sera and partially purified CA from ß-thalassemia patient samples.
|Figure 7: (a) Analysis of the carbonic anhydrase enzyme in healthy individuals and thalassemia patients by polyacrylamide gel electrophoresis 10% gel was stained for: (1) Crude sample of thalassemia patients. (2) Crude sample for healthy individuals. (b) (1) Crude sera from thalassemia patients. (2) Partially purified by ethanol and chloroform from thalassemia patients. (3) Partially purified by ammonium sulfate from thalassemia patient. (4) Dialysis from thalassemia patients. (5) Partially purified by gel filtration first band from thalassemia patients. (6) Partially purified by gel filtration second band from thalassemia patients. (7) Partially purified by gel filtration first band from thalassemia patients. (8) Partially purified by gel filtration second band from thalassemia patients|
Click here to view
[Figure 7]a indicates that the band which cleared in this figure represents the CA and the intensity of the band was less clear in patients samples compared to healthy individuals. These results confirmed those mentioned previously in [Table 1] for the CA activity. The results obtained in [Figure 7]b indicated that the CA was partially purified by the steps used in this study.
| Discussion|| |
The CAs are mostly zinc-containing metalloenzymes which catalyze the reversible hydration/dehydration of CO2/HCO3−; the CAs have been extensively studied because of their broad physiological importance in all kingdoms of life and clinical relevance as drug targets. The high catalytic rate, relatively simple procedure of expression and purification, relative stability, and extensive biophysical studies of HCA II have made it an exciting candidate to be incorporated into various biomedical applications such as artificial lungs, biosensors, and CO2 sequestration systems, among others. However, there had been few studies on the chemical characterization of CA from the human erythrocytes, Keilin and Mann, partially purified CA; in this study, CAs from healthy individuals and ß-thalassemia patients were partially purified using four sequential steps including extraction with ethanol and chloroform, AS precipitation, dialysis, and finally, using gel-filtration chromatography.
Different researchers had reported that CA in human erythrocytes may be fractionated to two and/or three or more fractions. Kyman separated three active fractions by column electrophoresis. Rickli and Edsall separated two active fractions by hydrophobic chromatography with phosphate buffers. Laurent et al. have separated three components by chromatography on Amberlite CG50 and have found them to contain CA activity, one being much more active than the other two. This study separated two fractions from CA erythrocytes using Sepharose 4B gel filtration, Fractions (I and II) from all studied groups. Tasgin et al. purified CA from bovine bone marrow using affinity chromatography using Sepharose 4B-L-tyrosine sulfanilamide, then investigated its kinetic properties. The present study also aimed to investigate the kinetic properties of CA, therefore, the CA which was purified from erythrocytes and then determined its kinetic properties.
To check the purity of the partially purified CA from previously purified steps, conventional electrophoresis analysis was carried out on the crude and partially purified CA in healthy and patient samples. It is obvious from [Figure 7] that the comparison between protein profile of the crude and the partially purified CA for the studied groups, the proteins in the crude separated into several protein bands and the purified samples showed less number and intensity bands which reflected that there were other proteins present in the crude sample which removed when the sample partially purified. It is clear from [Figure 7]a and [Figure 7]b that the blue bands were demonstrated in each of the crude and the purified CA of the studied groups, which could be concluded that the purified CAs appeared as a single band [Figure 7]b. The results of CA purification indicated that for both patients and healthy individuals with the first step (ethanol–chloroform extraction), best recovery and fold of purification were obtained. Demür et al. studied CA in the human erythrocyte membrane and using affinity chromatography to purify the enzyme.
| Conclusion|| |
The results of this study indicated that the CA was isolated from the human erythrocytes and can conclude that the best method to purify CA from the human erythrocytes with high recovery and fold of purification was ethanol–chloroform extraction.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Del Prete S, Vullo D, De Luca V, Supuran CT, Capasso C. Biochemical characterization of the δ-carbonic anhydrase from the marine diatom thalassiosira weissflogii, TweCA. J Enzyme Inhib Med Chem 2014;29:906-11.
Liljas A. Carbonic anhydrase under pressure. IUCrJ 2018;5:4-5.
Sauze J, Jones SP, Wingate L, Wohl S, Ogée J. The role of soil pH on soil carbonic anhydrase activity. Biogeosciences 2018;15:597-612.
Floryszak-Wieczorek J, Arasimowicz-Jelonek M. The multifunctional face of plant carbonic anhydrase. Plant Physiol Biochem 2017;112:362-8.
Supuran CT, Capasso C. An overview of the bacterial carbonic anhydrases. Metabolites 2017;7. pii: E56.
Supuran CT. Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168-81.
Kikutani S, Nakajima K, Nagasato C, Tsuji Y, Miyatake A, Matsuda Y, et al.
Thylakoid luminal θ-carbonic anhydrase critical for growth and photosynthesis in the marine diatom phaeodactylum tricornutum. Proc Natl Acad Sci U S A 2016;113:9828-33.
Aggarwal M, Boone CD, Kondeti B, McKenna R. Structural annotation of human carbonic anhydrases. J Enzyme Inhib Med Chem 2013;28:267-77.
Lindskog S. Structure and mechanism of carbonic anhydrase. Pharmacol Ther 1997;74:1-20.
Alterio V, Di Fiore A, D'Ambrosio K, Supuran CT, De Simone G. Multiple binding modes of inhibitors to carbonic anhydrases: How to design specific drugs targeting 15 different isoforms? Chem Rev 2012;112:4421-68.
Supuran CT. Carbonic anhydrases – An overview. Curr Pharm Des 2008;14:603-14.
Sly WS, Hu PY. Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu Rev Biochem 1995;64:375-401.
Supuran CT, Scozzafava A. Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem 2007;15:4336-50.
Parui R, Gambir KK, Cruz I, Hosten AO. Erythrocyte carbonic anhydrase: A major intracelluler enzyme to regulate cellular sodium metabolism in chronic renal failure patients with diabetes and hypertension. Int J Biochem 1992;26:809-20.
Parui R, Gambir KK, Mehrotra PP. Changes in carbonic anhydrase may be the initial step of altered metabolism in hypertension. Int J Biochem 1991;23:779-89.
Pastorekova S, Parkkila S, Pastorek J, Supuran CT. Carbonic anhydrases: Current state of the art, therapeutic applications and future prospects. J Enzyme Inhib Med Chem 2004;19:199-229.
Aggarwal M, McKenna R. Update on carbonic anhydrase inhibitors: A patent review (2008 – 2011). Expert Opin Ther Pat 2012;22:903-15.
Tu CK, Silverman DN, Forsman C, Jonsson BH, Lindskog S. Role of histidine 64 in the catalytic mechanism of human carbonic anhydrase II studied with a site-specific mutant. Biochemistry 1989;28:7913-8.
Mikulski RL, Silverman DN. Proton transfer in catalysis and the role of proton shuttles in carbonic anhydrase. Biochim Biophys Acta 2010;1804:422-6.
Silverman DN. Carbonic anhydrase: Oxygen-18 exchange catalyzed by an enzyme with rate-contributing proton-transfer steps. Methods Enzymol 1982;87:732-52.
Silverman DN, Lindskog S. The catalytic mechanism of carbonic anhydrase: Implications of a rate- limiting protolysis of water. Acc Chem Res 1988;21:30-6.
Silverman DN, McKenna R. Solvent-mediated proton transfer in catalysis by carbonic anhydrase. Acc Chem Res 2007;40:669-75.
Demir C, Demir H, Esen R, Atmaca M, Tagdemir E. Erythrocyte catalase and carbonic anhydrase activities in acute leukemias. Asian Pac J Cancer Prev 2010;11:247-50.
Russell BJ, Loesebrink B, Chernick V. Enhanced fetal erythrocyte carbonic anhydrase activity by hydrocortisone. Pediatr Res 1976;10:779-82.
Alvarez BV, Johnson DE, Sowah D, Soliman D, Light PE, Xia Y, et al.
Carbonic anhydrase inhibition prevents and reverts cardiomyocyte hypertrophy. J Physiol 2007;579:127-45.
Kuo WH, Yang SF, Hsieh YS, Tsai CS, Hwang WL, Chu SC, et al.
Differential expression of carbonic anhydrase isoenzymes in various types of anemia. Clin Chim Acta 2005;351:79-86.
Midiwo C, Okun D, Gwer S, Ogweno G. Plasma carbonic anhydrase II level is increased in children with sickle cell anaemia compared to healthy controls. Arch Paediatr Dev Pathol 2017;1:1013.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75.
Verpoorte JA, Mehta S, Edsall JT. Esterase activities of human carbonic anhydrases B and C. J Biol Chem 1967;242:4221-9.
Parui R, Gambhir KK, Cruz I, Hosten AO. Erythrocyte carbonic anhydrase: A major intracellular enzyme to regulate cellular sodium metabolism in chronic renal failure patients with diabetes and hypertension. Biochem Int 1992;26:809-20.
Ibrahim SI, Amodu AD, Ene-Ojo AS, Ismaila UA, Fakhrudeen M. Effect of hyperglycemia on erythrocyte carbonic anhydrase and lactic acid in type II diabetic subjects. J Diabetes Mellitus 2016;6:158-65.
Gambhir KK, Oates P, Verma M, Temam S, Cheatham W. High fructose feeding enhances erythrocyte carbonic anhydrase 1 mRNA levels in rat. Ann N Y Acad Sci 1997;827:163-9.
da Costa Ores J, Sala L, Cerveira GP, Kalil SJ. Purification of carbonic anhydrase from bovine erythrocytes and its application in the enzymic capture of carbon dioxide. Chemosphere 2012;88:255-9.
Amersham Biosciences. Protein Electrophoresis, Technical Manual. Hand Book. U.S.A.: Amersham Biosciences Inc.; 1999.
Osterman PO, Askmark H, Wistrand PJ. Serum carbonic anhydrase III in neuromuscular disorders and in healthy persons after a long-distance run. J Neurol Sci 1985;70:347-57.
Boone CD, Habibzadegan A, Gill S, McKenna R. Carbonic anhydrases and their biotechnological applications. Biomolecules 2013;3:553-62.
Keilin D, Mann T. Carbonic anhydrase. Purification and nature of the enzyme. Biochem J 1940;34:1163-76.
Nyman PO. Purification and properties of carbonic anhydrases from human erythrocytes. Biochim Biophys Acta 1961;62:1-12.
Rickli EE, Edsall JT. Zinc binding and the sulfhydryl group of human carbonic anhydrase. J Biol Chem 1962;237:PC258-60.
Laurent G, Marriq C, Nahon D, Charrel M, Der-Rien Y. On the proteins accompanying human hemoglobin in its preparations. I. Isolation and complexity of the non-heme protein. Compt Rend Sot Biol 1962;166:1456.
Laurent G, Charrel M, Marriq C, Derrien Y. Identification des protéines érythrocytaires Y, X1 et X2 aux anhydrases carboniques humaines. Bull Sot Chim Biol 1962;44:419.
Tasgin E, Nadaroglu H, Demir Y, Demir N. Purification and properties of carbonic anhydrase from bone marrow. Asian J Chem 2009;21:5117-22.
Demür N, Demür Y, Coþkun F. Purification and characterization of carbonic anhydrase from human erythrocyte plasma membrane. Turk J Med Sci 2001;31:477-82.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6], [Figure 7]
[Table 1], [Table 2], [Table 3], [Table 4]